49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details


臨床試験数 : 946 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 198

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01781611
(ClinicalTrials.gov)
February 20132/1/2013Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)Dipyridamole Assessment for Flare Reduction in SLESystemic Lupus ErythematosusDrug: extended release dipyridamole 200mg/aspirin 25mg;Drug: 81mg aspirinOklahoma Medical Research FoundationNULLTerminated18 Years70 YearsAll18N/AUnited States
2NCT00371501
(ClinicalTrials.gov)
June 20061/9/2006Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusLow Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled TrialAtherosclerosis;Thromboembolism;Systemic Lupus ErythematosusDrug: Rosuvastatin;Drug: placebo;Drug: aspirinTuen Mun HospitalAstraZenecaCompleted18 YearsN/ABoth72Phase 4Hong Kong
3NCT00731302
(ClinicalTrials.gov)
April 20055/8/2008Aspirin Resistance in Systemic Lupus Erythematosus (SLE)Vascular Damage in Systemic Lupus Erythematosus (SLE)Systemic Lupus ErythematosusDrug: aspirin and meloxicamVanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed18 YearsN/AAll70Phase 1United States
4NCT00054938
(ClinicalTrials.gov)
March 200313/2/2003Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot StudySystemic Lupus Erythematosus;LupusDrug: pravastatin;Drug: aspirin;Drug: ramipril;Drug: Vitamins: B6, B12, and folate;Behavioral: heart health educational programBrigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed18 YearsN/ABoth150Phase 2United States